MARKET

EDAP

EDAP

Edap Tms
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.965
-0.035
-0.88%
Closed 16:00 09/25 EDT
OPEN
4.050
PREV CLOSE
4.000
HIGH
4.060
LOW
3.895
VOLUME
34.89K
TURNOVER
--
52 WEEK HIGH
5.39
52 WEEK LOW
1.460
MARKET CAP
115.55M
P/E (TTM)
-60.6269
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
EDAP Hosting Key Opinion Leader Call on Focal One® and ExactVu™
Call to be Held Tuesday, September 22nd @ 8am Eastern TimeLYON, France, September 15, 2020 \-- EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced that it will host a key opinion leader (KOL) call on its two lead commercial products, Focal One® and ExactVu
GlobeNewswire · 09/15 12:00
EDAP's Shares March Higher, Can It Continue?
As of late, it has definitely been a great time to be an investor EDAP TMS.
Zacks · 09/10 11:22
EDAP Announces Presentation at the HC Wainwright Virtual 22nd Annual Global Investment Conference
LYON, France, September 9, 2020 -- EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced that management will be presenting at the HC Wainwright Virtual 22nd Annual Global Investment Conference, which is being held September 14-15, 2020.  Presentation details
GlobeNewswire · 09/09 12:00
EDAP TMS S.A. (EDAP) CEO Marc Oczachowski on Q2 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 08/27 17:40
EDAP TMS rallies on Q2 earnings beat
EDAP TMS S.A ([[EDAP]] +12.8%) Q2 total revenue of $10.3M, a decrease of 26% vs. same period 2019, beating consensus by $4.08M.Revenue break-up: HIFU business-$2.8M (-42% Y/Y), LITHO business- $3.3M (-22.8%
Seekingalpha · 08/27 16:30
EDAP Reports Second Quarter 2020 Results and Provides Operational Update
* Completed multiple Focal One sales to renowned U.S. and international health care institutions, including multiple Focal One™-ExactVu™ bundled sales * Announced first two U.S. publications in Journal of Urology detailing positive outcomes from U.S. studies of HIFU for the successful partial-gland
GlobeNewswire · 08/26 21:35
EDAP TMS S.A. EPS beats by $0.06, beats on revenue
EDAP TMS S.A. (EDAP): Q2 GAAP EPS of -$0.01 beats by $0.06.Revenue of $10.24M (-27.1% Y/Y) beats by $4.08M.Press Release
Seekingalpha · 08/26 20:37
EDAP TMS on go with study of Focal One HIFU to treat rectal endometriosis
Seeking Alpha - Article · 08/25 12:54
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of EDAP. Analyze the recent business situations of Edap Tms through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average EDAP stock price target is 5.25 with a high estimate of 5.42 and a low estimate of 4.923.
EPS
Institutional Holdings
Institutions: 43
Institutional Holdings: 5.12M
% Owned: 17.57%
Shares Outstanding: 29.14M
TypeInstitutionsShares
Increased
4
140.39K
New
8
-513.29K
Decreased
8
389.81K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+1.83%
Healthcare Equipment & Supplies
+2.01%
Key Executives
Chairman/Chief Executive Officer/Director
Marc Oczachowski
Chief Financial Officer
Francois Dietsch
Director
Marie Meynadier
Independent Director
Robrecht Michiels
Independent Director
Pierre Beysson
Independent Director
Rob Michiels
Independent Director
Argil Wheelock
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About EDAP
EDAP TMS S.A. (EDAP) is a company that develops, manufactures, promotes and distributes minimally-invasive medical devices for urology based upon proprietary ultrasound technology. The Company operates worldwide via an extensive network of corporate offices, subsidiaries and distribution partners. The Company invests in Research & Development, partnering with INSERM French public laboratory and international medical research institutions. Company's activity is organized in two divisions: HIFU and UDS (including lithotripsy activities). The Company is developing HIFU technology (High Intensity Focused Ultrasound) in non-invasive treatment of prostate conditions with its range of Robotic HIFU devices, Ablatherm Fusion and Focal One. The Company is also developing ESWL (Extracorporeal ShockWave Lithotripsy) and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Edap Tms SA (ADR) stock information, including NASDAQ:EDAP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EDAP stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading EDAP stock methods without spending real money on the virtual paper trading platform.